Understanding the Dietary Adjustments Following GLP-1 Agonist Treatment: The GLaD Feasibility Study
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Feasibility of recruitment
研究概览
简要总结
An observational study of those who have been prescribed a GLP-1 agonist therapy (yet to commence), for either weight or diabetes management, and are willing to complete dietary records and questionnaires of behaviour and psychosocial health.
详细描述
Forty individuals (20 for weight management, 20 for diabetes management) living in Australia who have been prescribed a GLP-1 agonist (no previous prescription or no use in the previous 6 months) will be recruited to participate over the initial 3 months of their treatment. Assessments will occur remotely (online) at baseline, 2 weeks, 1 month and 3 months. Optional body composition assessments will be provided at baseline and 3 months for those based in Melbourne, Australia.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Aged 18+ years old
- •Intending to commence a prescription for a GLP-1 agonist (may be dual agonist, i.e. Ozempic, Trulicity, Monjaro, or Saxenda) medication, with no use in the previous 6 months
- •The primary reason for commencing the medication will be for diabetes or weight management
- •Willing to participate in dietary recall and questionnaires
排除标准
- •Aged under 18 years,
- •used a GLP-1 agonist medication in the previous 6 months,
- •unwilling or unable to provide dietary recalls
- •non-English speaking.
结局指标
主要结局
Feasibility of recruitment
时间窗: 4 months
The rate of recruitment and the retention rate of participants completing the dietary assessment measures.
次要结局
- Energy intake(baseline, 2 weeks, 1 month, 3 months)
- Medication symptomology(baseline, 1 month, 3 months)
- Medication use(baseline, 1 month, 3 months)